RaQualia Pharma Inc.
4579.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥495 | -¥324 | ¥851 | ¥881 |
| Dep. & Amort. | ¥402 | ¥176 | ¥148 | ¥142 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | ¥52 | -¥460 | ¥677 | -¥460 |
| Other Non-Cash | ¥222 | -¥110 | -¥196 | -¥197 |
| Operating Cash Flow | ¥181 | -¥719 | ¥1,480 | ¥366 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥97 | -¥222 | -¥32 | -¥105 |
| Net Acquisitions | -¥3,880 | ¥0 | ¥0 | -¥14 |
| Inv. Purchases | -¥200 | -¥260 | -¥952 | -¥718 |
| Inv. Sales/Matur. | ¥359 | ¥350 | ¥936 | ¥544 |
| Other Inv. Act. | ¥152 | -¥3 | -¥0 | ¥14 |
| Investing Cash Flow | -¥3,666 | -¥135 | -¥48 | -¥279 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥2,902 | ¥40 | ¥12 | -¥18 |
| Stock Issued | ¥80 | ¥787 | ¥4 | ¥2 |
| Stock Repurch. | -¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Fin. Act. | ¥80 | -¥52 | -¥45 | ¥0 |
| Financing Cash Flow | ¥2,982 | ¥793 | -¥30 | -¥16 |
| Forex Effect | -¥20 | ¥46 | ¥36 | ¥109 |
| Net Chg. in Cash | -¥523 | -¥15 | ¥1,439 | ¥179 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥3,665 | ¥3,679 | ¥2,241 | ¥2,061 |
| End Cash | ¥3,142 | ¥3,665 | ¥3,679 | ¥2,241 |
| Free Cash Flow | ¥84 | -¥941 | ¥1,448 | ¥261 |